New York, New York – Rising global tensions and recent strikes involving nuclear-linked infrastructure are prompting renewed attention across New York, where millions live within range of two active nuclear power plants.
According to the U.S. Food and Drug Administration and New York State emergency guidance, potassium iodide, or KI, can help protect the thyroid from radioactive iodine if taken at the right time. A recent ballistic missile strike on a nuclear-related facility in Iran did not result in radiation release, but officials say it serves as a reminder of how quickly situations involving nuclear infrastructure can escalate.
New York is home to the Nine Mile Point and James A. FitzPatrick nuclear power plants near Oswego along Lake Ontario, with dense population centers including Buffalo and parts of Central New York within broader impact zones depending on wind direction.
KI works by saturating the thyroid with stable iodine, reducing the body’s ability to absorb radioactive iodine during exposure. That protection is most effective if taken shortly before or immediately after exposure, with effectiveness dropping after several hours. It only protects the thyroid and does not shield other organs or reverse existing damage.
Communities from Buffalo to Syracuse and into the Capital Region could face varying levels of exposure in a worst-case scenario, underscoring the importance of understanding protective actions in advance.
Emergency officials stress evacuation or sheltering in place remains the primary protection strategy. KI is considered a secondary layer of defense and should only be taken when directed by public health authorities.
Iodine is also safely used in controlled medical treatments for thyroid conditions, demonstrating its targeted effectiveness when properly administered.
Residents are encouraged to review emergency plans and consider access to KI tablets, as guidance could be issued rapidly during any nuclear-related emergency.
